Cargando…

Blood SSR1: A Possible Biomarker for Early Prediction of Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease associated with age. Early diagnosis of PD is key to preventing the loss of dopamine neurons. Peripheral-blood biomarkers have shown their value in recent years because of their easy access and long-term monitoring advantag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wen, Shen, Jiabing, Wang, Yuhui, Cai, Kefu, Zhang, Qi, Cao, Maohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924528/ https://www.ncbi.nlm.nih.gov/pubmed/35310885 http://dx.doi.org/10.3389/fnmol.2022.762544

Ejemplares similares

SKP-SCs transplantation alleviates 6-OHDA-induced dopaminergic neuronal injury by modulating autophagy
por: Ma, Chengxiao, et al.
Publicado: (2021)

The application of weighted gene co-expression network analysis and support vector machine learning in the screening of Parkinson’s disease biomarkers and construction of diagnostic models
por: Cai, Lijun, et al.
Publicado: (2023)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Possible mechanisms of treatment for spinal cord injury repair with tanshinone IIA
por: Jia, Zhiwei, et al.
Publicado: (2023)

A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
por: Wang, Xueying, et al.
Publicado: (2023)

Role of the Peripheral Nervous System in PD Pathology, Diagnosis, and Treatment
por: Ma, Chengxiao, et al.
Publicado: (2021)

Peripheral Blood Circular RNAs as a Biomarker for Major Depressive Disorder and Prediction of Possible Pathways
por: Zhang, Dandan, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals the Müller subtypes and inner blood–retinal barrier regulatory network in early diabetic retinopathy
por: Wang, Yan, et al.
Publicado: (2022)

Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
por: Santiago, Jose A., et al.
Publicado: (2018)

Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer’s Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2021)

Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2022)

A mini-review of the role of vesicular glutamate transporters in Parkinson’s disease
por: Zhao, Cheng, et al.
Publicado: (2023)

Identification of mitochondrial-related genes as potential biomarkers for the subtyping and prediction of Alzheimer’s disease
por: Ma, Wenhao, et al.
Publicado: (2023)

The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
por: Lee, Davin, et al.
Publicado: (2021)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Miro1 Impairment in a Parkinson’s At-Risk Cohort
por: Nguyen, David, et al.
Publicado: (2021)

Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation
por: Mesa-Herrera, Fátima, et al.
Publicado: (2022)

DNA methylation meningioma biomarkers: attributes and limitations
por: Li, Zhaohui, et al.
Publicado: (2023)

Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018)

Circulating CircRNAs Panel Acts as a Biomarker for the Early Diagnosis and Severity of Parkinson’s Disease
por: Zhong, Lingling, et al.
Publicado: (2021)

Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers
por: Zhang, Meng, et al.
Publicado: (2021)

Association of the Polygenic Risk Score With the Probability of Prodromal Parkinson’s Disease in Older Adults
por: Maraki, Maria I., et al.
Publicado: (2021)

Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
por: Brembati, Viviana, et al.
Publicado: (2023)

microRNAs profiling of small extracellular vesicles from midbrain tissue of Parkinson’s disease
por: Li, Zhengzhe, et al.
Publicado: (2023)

Biomarkers and the outcomes of ischemic stroke
por: Huang, Ying, et al.
Publicado: (2023)

Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
por: Tiklová, Katarína, et al.
Publicado: (2021)

Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer’s and Parkinson’s disease
por: Gok, Muslum, et al.
Publicado: (2022)

MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
por: Arshad, Ahmad R., et al.
Publicado: (2017)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
por: He, Xiaoqin, et al.
Publicado: (2022)

Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome
por: Nashiry, Md Asif, et al.
Publicado: (2023)

Peripheral metabolic alterations associated with pathological manifestations of Parkinson’s disease in gut-brain axis-based mouse model
por: Huh, Eugene, et al.
Publicado: (2023)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Novel diagnostic biomarkers related to immune infiltration in Parkinson’s disease by bioinformatics analysis
por: Zhang, Pengfei, et al.
Publicado: (2023)

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
por: Ma, Ling-Yan, et al.
Publicado: (2021)

MicroRNAs Play a Role in Parkinson’s Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential
por: Li, Silu, et al.
Publicado: (2022)

The Potential Circular RNAs Biomarker Panel and Regulatory Networks of Parkinson’s Disease
por: Xiao, Yousheng, et al.
Publicado: (2022)

X-Vectors: New Quantitative Biomarkers for Early Parkinson's Disease Detection From Speech
por: Jeancolas, Laetitia, et al.
Publicado: (2021)

Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder
por: Bao, Xiao-Hong, et al.
Publicado: (2023)

Synapse-associated protein 102 – a highly mobile MAGUK predominate in early synaptogenesis
por: De Los Reyes, Dominique Alexandra, et al.
Publicado: (2023)

Decreased soluble Nogo-B in serum as a promising biomarker for Parkinson's disease
por: Liang, Hongming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tjbvguqbea7spr2ef5g8l0gl76